Company profile for Shanghai Pharmaceuticals Holding Co.,Ltd

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a national pharmaceutical group headquartered in Shanghai, China. The Company's principal business covers the whole industrial value chain ranging from pharmaceutical R&D, manufacturing, distribution and retailing. In 2012, the Company had reportedly the business revenues of RMB 68 billion ranking No. 2 in the Chinese pharmaceutical industry in terms of the composite capabilities a...
Shanghai Pharmaceuticals Holding Co., Ltd. is a national pharmaceutical group headquartered in Shanghai, China. The Company's principal business covers the whole industrial value chain ranging from pharmaceutical R&D, manufacturing, distribution and retailing. In 2012, the Company had reportedly the business revenues of RMB 68 billion ranking No. 2 in the Chinese pharmaceutical industry in terms of the composite capabilities among the top 500 Chinese enterprises according to Chinese Enterprise Confederation, The company is the one of the few listed pharmaceutical companies which holds a leading position in both pharmaceutical manufacturing and distribution in China.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No.200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai 200 020
Telephone
Telephone
+86 216 373 0908
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/immvira-announces-us10-million-strategic-series-b-plus-financing-with-siic-capital-301136859.html

PRNEWSWIRE
24 Sep 2020

https://www.prnewswire.com/news-releases/immvira-and-shanghai-pharma-announce-clinical-collaboration-and-license-agreement-for-commercialization-of-novel-intratumoral-oncolytic-virus-immunotherapies-301107817.html

PRNEWSWIRE
06 Aug 2020

https://en.prnasia.com/releases/global/shanghai-pharma-global-standard-stock-incentive-scheme-to-push-innovation-refiled-for-approval-259567.shtml

PRNASIA
02 Oct 2019
Takeda eyes $3B from emerging-market asset cull
Takeda eyes $3B from emerging-market asset cull

22 Jan 2019

// Angius Liu FIERCE PHARMA

https://www.fiercepharma.com/pharma/3b-emerging-market-assets-could-be-next-takeda-s-chopping-board-report

Angius Liu FIERCE PHARMA
22 Jan 2019

https://www.biospectrumasia.com/news/25/10950/shanghai-pharma-bracco-imaging-sign-new-agreement.html

BIOSPECTRUM
23 May 2018

https://endpts.com/takeda-bags-280m-sells-off-its-stake-in-a-china-drug-jv-ahead-of-62b-shire-buyout/

John Carroll ENDPTS
23 May 2018

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Shanghai Pharmaceuticals Holding Co.,Ltd and get a quotation

Shanghai Pharmaceuticals Holding Co.,Ltd is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Griseofulvin bulk offered by Shanghai Pharmaceuticals Holding Co.,Ltd

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty